Apotheka Pharma Vaistinė - Company finances
|
EUR
|
2019
From: 2019-05-01
To: 2020-04-30
|
2020
From: 2020-05-01
To: 2021-04-30
|
2021
From: 2021-05-01
To: 2022-04-30
|
2022
From: 2022-05-01
To: 2023-04-30
|
2023
From: 2023-05-01
To: 2024-04-30
|
2024
From: 2024-05-01
To: 2025-04-30
|
2025
From: 2025-05-01
To: 2026-04-30
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 852,699 | 2,338,567 | 4,826,119 | 7,881,802 | 7,488,378 | 6,824,494 | 7,949,433 |
| Profit before tax | -1,064,366 | -1,895,042 | -2,853,217 | -3,808,139 | -3,670,873 | -3,436,996 | -3,269,680 |
| Net profit | -1,064,366 | -1,895,042 | -2,853,217 | -3,808,139 | -3,670,873 | -3,436,996 | -3,269,680 |
| Equity | -1,141,561 | -3,036,602 | -5,889,819 | -9,697,958 | -13,368,831 | -16,805,827 | -20,075,508 |
| Liabilities | 2,698,381 | 5,058,311 | 8,268,761 | 12,080,442 | 15,427,709 | 18,397,143 | 21,838,324 |
| Non-current assets | 762,958 | 994,538 | 991,641 | 630,622 | 316,972 | 172,258 | 146,814 |
| Current assets | 792,544 | 1,026,335 | 1,383,524 | 1,765,048 | 1,752,522 | 1,428,170 | 1,608,480 |
| Total assets | 1,555,502 | 2,020,873 | 2,375,165 | 2,395,670 | 2,069,494 | 1,600,428 | 1,755,294 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 394,600 | 271,347 | 219,725 |
| Social insurance contributions | - | - | - | - | 500,304 | 420,683 | 463,305 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +174.3% | +106.4% | +63.3% | -5.0% | -8.9% | +16.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -68.4% | -93.8% | -120.1% | -159.0% | -177.4% | -214.8% | -186.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -124.8% | -81.0% | -59.1% | -48.3% | -49.0% | -50.4% | -41.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -124.8% | -81.0% | -59.1% | -48.3% | -49.0% | -50.4% | -41.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 51,994 | 51,397 | 90,916 | 119,120 | 131,567 | 140,711 | 160,056 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Apotheka Pharma Vaistinė - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-08-17 | 2023-08-24 | 9728.21 |
| 2023-07-27 | 2023-07-30 | 495.69 |
| 2023-07-24 | 2023-07-26 | 497.80 |
| 2023-07-19 | 2023-07-23 | 423.41 |
| 2023-07-18 | 2023-07-18 | 45036.41 |
| 2023-06-16 | 2023-06-18 | 49195.10 |
| 2023-05-16 | 2023-05-23 | 310.69 |
| 2023-05-04 | 2023-05-14 | 88.34 |
| 2023-05-02 | 2023-05-03 | 3547.16 |
| 2023-04-27 | 2023-04-28 | 3547.16 |
| 2023-04-26 | 2023-04-26 | 3458.82 |
| 2023-04-25 | 2023-04-25 | 3547.16 |
| 2023-04-18 | 2023-04-24 | 3458.82 |
| 2023-02-17 | 2023-02-20 | 41702.05 |
| 2023-02-06 | 2023-02-16 | 23.27 |
| 2023-01-23 | 2023-02-03 | 23.27 |
| 2023-01-17 | 2023-01-18 | 42586.12 |
| 2022-10-28 | 2022-11-14 | 67.26 |
| 2022-08-23 | 2022-09-15 | 259.24 |
| 2022-07-26 | 2022-08-22 | 49.92 |
| 2022-07-25 | 2022-07-25 | 826.24 |
| 2022-07-20 | 2022-07-24 | 776.32 |
| 2022-07-18 | 2022-07-19 | 8347.81 |
| 2022-04-25 | 2022-05-15 | 76.21 |
| 2022-04-19 | 2022-04-24 | 28.97 |
| 2022-03-16 | 2022-03-16 | 30131.88 |
| 2022-02-17 | 2022-02-17 | 32450.03 |
| 2021-10-18 | 2021-10-19 | 24596.72 |
| 2021-09-16 | 2021-09-20 | 24056.04 |
Apotheka Pharma Vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.